If you have specific inquiries regarding the topics listed below, please click on the relevant link below and you will be redirected to the appropriate site for assistance.
Stockholders and other interested parties may communicate directly with an individual independent director, a committee chair or the independent directors as a group as follows:
|Send an e-mail to:
c/o Office of the Chief Legal Officer
300 Park Avenue
New York, NY 10022-7499
Under procedures established by Colgate's independent directors, each letter and e-mail sent in accordance with the above instructions is reviewed by the Legal Department. Communications will be forwarded to an individual director, a committee chair or the independent directors as a group as appropriate.
Significant concerns and questions relating to accounting, internal accounting controls or auditing matters are promptly brought to the attention of the Audit Committee chair of Colgate's Board of Directors and are handled in accordance with the procedures established by the Audit Committee. Under these procedures, the Company's Global Ethics and Compliance function, in conjunction with the Company's Internal Audit and Corporate Legal departments, addresses these concerns in accordance with the directions of the Audit Committee chair. The Audit Committee chair approves recommendations regarding the handling of each matter, oversees any investigations and approves the disposition of each matter. The Audit Committee chair may, in his discretion, engage outside counsel and other independent advisors. The Audit Committee receives quarterly updates regarding other concerns or questions relating to accounting, internal accounting controls or auditing matters.
Concerns relating to accounting, internal accounting controls and auditing matters may also be reported to the Global Ethics and Compliance function by telephone, facsimile and e-mail as follows:
||(800) 778-6080 (toll free from United States, Canada and Puerto Rico) or (212) 310-2330
(collect from all other locations)
Colgate policy prohibits the Company from retaliating against any individual who provides information to the directors. Concerns may be submitted to the directors on an anonymous basis through their postal address or through the 24-hour EthicsLine numbers maintained by the Global Ethics and Compliance function. If requested, Colgate will take all appropriate steps to keep information submitted confidential, subject to the need to conduct an effective investigation and take appropriate action or as otherwise required by applicable law.